ProfileGDS5678 / 1443419_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 50% 51% 50% 48% 51% 54% 51% 50% 50% 50% 50% 50% 51% 50% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.246650
GSM967853U87-EV human glioblastoma xenograft - Control 23.2088751
GSM967854U87-EV human glioblastoma xenograft - Control 33.2009950
GSM967855U87-EV human glioblastoma xenograft - Control 43.0900148
GSM967856U87-EV human glioblastoma xenograft - Control 53.189751
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4345354
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3193351
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1956650
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1682750
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1940550
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2016550
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1705850
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2290751
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2049350